ImmunoCAP™ ECP measures the level of Eosinophil Cationic Protein (ECP) in serum. Eosinophils are the cells chiefly responsible for producing the inflammation associated with some types of asthma. When eosinophils in the airway are activated, they undergo degranulation and release ECP, causing airway epithelial damage. The level of ECP correlates with the level of inflammation in asthmatic patients.
Asthmatic patients with eosinophilic inflammation have elevated levels of ECP.1,2
ImmunoCAP ECP can help you identify the severity of the airway inflammation1 and aids in determining appropriate therapy for patients with asthma.